Coronavirus Conversations: The Science and Ethics of Human Challenge Trials for COVID-19

Co-Hosted with The Duke Center on Risk, and The Petrie-Flom Center For Bioethics at Harvard University

Human challenge trials for COVID-19 offer an opportunity to speed the development of treatments and vaccines that can help tame the pandemic. But they are risky for participants and pose thorny ethical questions. Even with willing volunteers, the scientific and medical communities must carefully weigh the risks before launching any human challenge trials and put strong ethical safeguards in place.

Join Duke Science & Society, Harvard Petrie-Flom Center For BioEthics, and The Duke Center on Risk and our panel of experts in a discussion of the science, promise, and risks of human challenge trials, how they might play a role in bringing an end to the coronavirus pandemic, and how to legally and ethically do so.

Panelists:

Dr. Marc Lipsitch, Harvard School of Public Health, Department of Epidemiology & Department of Immunology and Infectious Disease; Director, Center for Communicable Disease Dynamics

Dr. Nir Eyal, Rutgers University, Henry Rutgers Professor of Bioethics; Director of The Center for Population-Level Bioethics (CPLB); Department of Health Behavior, Society, and Policy

Dr. Cameron Wolfe, Infectious Disease Specialist, Associate Professor of Medicine; Clinical Expert In Respiratory and Infectious Disease, Duke Medical School

Moderator:

Kim Krawiec, J.D., Duke University School of Law, Kathrine Robinson Everett Professor of Law

[DrissBounouar]

You have to work on the sound... USE EARPHONES